Jason H. Goodchild, DMD
LectureThis course qualifies for providing credit for the DEA MATE Act training requirement.
Course Description
This course qualifies for providing credit for the DEA MATE Act training requirement.
On March 28, 2023 the U.S. Drug Enforcement Administration (DEA) issued guidance outlining requirements for a one-time, eight-hour training, “on the treatment and management of patients with opioid or other substance use disorders.” The Medication Access and Training Expansion (MATE) Act that was passed as part of the Consolidated Appropriations Act (CAA) of 2023 (P.L. 117-328) requires all DEA-registered providers to complete this training. This means YOU!
The deadline to satisfy this training requirement is the date of a practitioner’s next scheduled DEA registration submission beginning June 27, 2023. Practitioners will be required to check a box on their online DEA registration form to affirm that they have completed the training, regardless of whether the practitioner is a first-time applicant or is renewing their registration.
Wouldn’t it be nice to complete this requirement from the comfort of your own home and at your own pace? Wouldn’t it be nice to avoid the costs of additional travel and time in having to attend an in-person continuing educational event? Wouldn’t you like to avoid the typical four hours of pre-course work often required by these live programs? This is the course for you.
In partnership with two PACE and CERP accredited, university-based continuing educational teams, our faculty is proud to be affiliated with the Oregon Health & Sciences University and the University of Washington to bring this foundational course to your home or office. In compliance with the DEA requirements for this new comprehensive curriculum, we will cover the safe pharmacological management of dental pain and screening, brief intervention, and referral for appropriate treatment of patients with or at risk of developing opioid and other substance use disorders.
Our first module will focus on the appropriate office-based approach in helping manage these challenging patients, emphasizing strategies that focus on patient comfort and helping set you, your team and most importantly, your patients up for success. This module is foundational in setting the stage for the second module in our continuum which continues the themes of patient and medication safety and focuses on successful evidence- and guideline-based strategies for appropriate postoperative analgesic prescribing.
Combined, these interactive programs will review the current clinical challenges and regulatory issues with a particular focus on the dental realm. Case studies will augment the delivery of key points and a problem-based learning approach is encouraged so that each participant’s questions are addressed.
Course Objectives
- Discuss the Medication Access and Training Expansion (MATE) Act
- Understand the DEA requirements for this new comprehensive curriculum
- Describe the safe pharmacological management of dental pain and screening, with a focus on excellent intraoperative local anesthesia
- Explain successful evidence- and guideline-based strategies for appropriate perioperative pain management
- Describe referral for appropriate treatment of patients with or at risk of developing opioid and other substance use disorders
Instructor
Jason Goodchild is a graduate of Dickinson College in Carlisle, PA. He received his dental training at the University of Pennsylvania School of Dental Medicine. Dr. Goodchild serves as Associate Professor & Chairman of the Department of Diagnostic Sciences at Creighton University School of Dentistry (Omaha, NE). Recently, he joined the Premier Dental Products Company in Plymouth Meeting, PA as the Director of Clinical Affairs. He has published numerous articles and lectures internationally on the topics of treatment planning, treatment of medical complex patients, restorative dentistry, pharmacology, emergency medicine in dentistry, enteral sedation dentistry, and dental photography. He has been an invited speaker for the Academy of General Dentistry and American Association of Dental Examiners. He is a reviewer for the Journal of the American Dental Association, General Dentistry, and Quintessence International. Dr. Goodchild maintains a private general dental practice in Havertown, PA.
Disclosures:
- Dr. Goodchild has no relevant financial relationships to disclose.
- The staff of the University of Washington Office of Continuing Dental Education have no relevant financial relationships to disclose.
Course Logistics
DATE:
Saturday, June 17, 2023
LOCATION:
Zoom live webinar
TARGET AUDIENCE:
This course is designed for dentists who prescribe opioids in their offices.
TIMES:
Course: 8:30am – 12:30pm
TUITION:
$159/Dentist
$99/Team members (dental hygienist, dental assistant, office staff)
$143/Current Dental Alumni Member
* This course is eligible for a 10% tuition discount if you are a current member of the UW Dental Alumni Association.
CREDITS:
4 hours
The University of Washington is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at CCEPR.ADA.org.
This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint efforts between the University of Washington and Oregon Health Sciences University Offices of Continuing Dental Education.
The University of Washington is a member of the Association for Continuing Dental Education.
University of Washington designates this activity for 4 continuing education credits.